Page last updated: 2024-08-23

rolafagrel and Hyperlipemia

rolafagrel has been researched along with Hyperlipemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albertazzi, L; Calandra, S; Marchi, L; Nicolini, S; Salvati, P; Tarugi, P1
Benigni, A; Bianchi, G; Braidotti, P; Duzzi, L; Ferrario, RG; Ferti, C; Lamberti, E; Perico, N; Remuzzi, G; Salvati, P1

Other Studies

2 other study(ies) available for rolafagrel and Hyperlipemia

ArticleYear
The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
    Aging (Milan, Italy), 1994, Volume: 6, Issue:5

    Topics: Aging; Animals; Apolipoproteins A; Apolipoproteins E; Body Weight; Disease Models, Animal; Hyperlipidemias; Imidazoles; Lipid Metabolism; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Naphthalenes; Nephrotic Syndrome; Proteinuria; Rats; Rats, Inbred Strains; Thromboxane-A Synthase

1994
Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease.
    Kidney international, 1990, Volume: 38, Issue:3

    Topics: Animals; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Hypertension; Imidazoles; Kidney Glomerulus; Male; Naphthalenes; Rats; Rats, Inbred SHR; Thromboxane A2; Thromboxane-A Synthase; Time Factors

1990